← Leaderboards
Prakash Chinnaiyan
William Beaumont Hospital Research Inst
$3,215,491
Attributed
$3,215,491
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $713.5K · FY2016–25$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,215,491 · 3
By mechanism
R01$2,797,491 · 2
R21$418,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Complex”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$385,971,304
- Chanza Baytop · Westat, Inc.$271,217,917
- David R. Weir · University Of Michigan At Ann Arbor$186,776,551
- Barton F Haynes · Duke University$162,931,717
Research focus
ComplexMetabolic PathwayIn VivoGlioblastomaTumorMetabolomicsMalignant NeoplasmsInvestigationMetabolicCellsPre-Clinical ModelMetabolismPhenotypePlayCancer TherapySeriesLaboratory StudyDesignCouplingAggressive TherapyGenomicsCombinatorialResearch DesignTumor Metabolism
Grant awards (10)
Quinolinate-induced immune suppression in glioblastoma$380,000
R01 · FY2025 · NS · contact PI
Quinolinate-induced immune suppression in glioblastoma$368,600
R01 · FY2024 · NS · contact PI
Developing therapeutic strategies to elicit metabolic synthetic lethality in glioblastoma$323,500
R01 · FY2024 · NS · contact PI
Quinolinate-induced immune suppression in glioblastoma$380,000
R01 · FY2023 · NS · contact PI
Developing therapeutic strategies to elicit metabolic synthetic lethality in glioblastoma$333,504
R01 · FY2023 · NS · contact PI
Developing therapeutic strategies to elicit metabolic synthetic lethality in glioblastoma$333,504
R01 · FY2022 · NS · contact PI
Developing therapeutic strategies to elicit metabolic synthetic lethality in glioblastoma$336,769
R01 · FY2021 · NS · contact PI
Developing therapeutic strategies to elicit metabolic synthetic lethality in glioblastoma$341,614
R01 · FY2020 · NS · contact PI
Biologic consequence and therapeuticimplications of cysteine catabolism in glioblastoma$228,000
R21 · FY2017 · NS · contact PI
Biologic consequence and therapeuticimplications of cysteine catabolism in glioblastoma$190,000
R21 · FY2016 · NS · contact PI